propiverine has been researched along with Lower Urinary Tract Symptom in 3 studies
propiverine: anticholinergic used for overactive bladder syndrome
| Excerpt | Relevance | Reference |
|---|---|---|
| "The efficacy and safety of treatment with alfuzosin 10 mg plus propiverine 10 or 20 mg in men with lower urinary tract symptoms (LUTS) and an overactive bladder were investigated." | 9.19 | Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study. ( Cho, HJ; Cho, JM; Kang, JY; Moon, HS; Seo, DY; Shin, SC; Sung, LH; Yoo, TK; Yu, JH, 2014) |
| "Naftopidil is an alpha-blocker (AB) that has a high affinity for the A1d receptor that may have advantages in treating LUTS in this setting." | 6.58 | Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. ( Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R, 2018) |
| "Propiverine is a well established antimuscarinic agent with a mixed mode of action in the treatment of symptoms associated with overactive bladder (OAB)." | 6.49 | Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms. ( McKeage, K, 2013) |
| "The efficacy and safety of treatment with alfuzosin 10 mg plus propiverine 10 or 20 mg in men with lower urinary tract symptoms (LUTS) and an overactive bladder were investigated." | 5.19 | Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study. ( Cho, HJ; Cho, JM; Kang, JY; Moon, HS; Seo, DY; Shin, SC; Sung, LH; Yoo, TK; Yu, JH, 2014) |
| "Naftopidil is an alpha-blocker (AB) that has a high affinity for the A1d receptor that may have advantages in treating LUTS in this setting." | 2.58 | Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia. ( Dahm, P; Gandhi, S; Hwang, EC; Imamura, M; Jung, JH; Kim, MH; Pang, R, 2018) |
| "Propiverine is a well established antimuscarinic agent with a mixed mode of action in the treatment of symptoms associated with overactive bladder (OAB)." | 2.49 | Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms. ( McKeage, K, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hwang, EC | 1 |
| Gandhi, S | 1 |
| Jung, JH | 1 |
| Imamura, M | 1 |
| Kim, MH | 1 |
| Pang, R | 1 |
| Dahm, P | 1 |
| Cho, HJ | 1 |
| Shin, SC | 1 |
| Seo, DY | 1 |
| Cho, JM | 1 |
| Kang, JY | 1 |
| Yoo, TK | 1 |
| Yu, JH | 1 |
| Sung, LH | 1 |
| Moon, HS | 1 |
| McKeage, K | 1 |
2 reviews available for propiverine and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia.
Topics: Adrenergic alpha-Antagonists; Benzilates; Drug Combinations; Ethamsylate; Humans; Indoles; Lower Uri | 2018 |
Propiverine: a review of its use in the treatment of adults and children with overactive bladder associated with idiopathic or neurogenic detrusor overactivity, and in men with lower urinary tract symptoms.
Topics: Adolescent; Adult; Age Factors; Benzilates; Child; Child, Preschool; Drug Therapy, Combination; Fema | 2013 |
1 trial available for propiverine and Lower Urinary Tract Symptom
| Article | Year |
|---|---|
Comparison of alfuzosin 10 mg with or without propiverine 10 mg, 20 mg in men with lower urinary tract symptom and an overactive bladder: randomised, single-blind, prospective study.
Topics: Benzilates; Drug Therapy, Combination; Humans; Lower Urinary Tract Symptoms; Male; Middle Aged; Pros | 2014 |